Clinical Trial

Initial Evaluation of Vascudyne Coronary Artery Bypass Conduit

Study acronym: VCAB-1
Enrolling by Invitation Early Phase 1
View on ClinicalTrials.gov →
Summary
The Vascudyne Coronary Artery Bypass Study (VCAB-1) is an initial safety and feasibility study of the Vascudyne, Inc. Coronary Artery Bypass Conduit (CAB A) for bypass of stenosed native coronary arteries in patients undergoing coronary artery bypass surgery.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-05-23; most recent amendment 2025-12-02.
Trial Details
NCT Number NCT06434935
Lead Sponsor Vascudyne, Inc.
Conditions Coronary Artery Disease
Enrollment 5 participants
Start Date 2024-06-13
Primary Completion 2026-08 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2025-12-10